,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2018-07-14 23:05:00,Picking dividend stocks with high yields is only part of the equation for dividend investors.,0.028888458386063576,0.0100239347666502,0.9610875844955444,neutral,0.018864523619413376
1,2018-07-14 23:05:00,A high yield means nothing if that dividend eventually gets slashed.,0.09302373975515366,0.3427397310733795,0.5642365217208862,neutral,-0.24971598386764526
2,2018-07-14 23:05:00,Companies with long track records and durable competitive advantages are what you should be after.,0.260171502828598,0.007902303710579872,0.7319262027740479,neutral,0.2522692084312439
3,2018-07-14 23:05:00,Three of our Motley Fool investors have identified three dividend stocks that you can safely bet on for years to come.,0.10082705318927765,0.005707505624741316,0.8934654593467712,neutral,0.09511955082416534
4,2018-07-14 23:05:00,"Here's what you need to know about Verizon (NYSE: VZ) , Eli Lilly (NYSE: LLY) , and Procter & Gamble (NYSE: PG) .",0.01682542823255062,0.007353766821324825,0.975820779800415,neutral,0.009471661411225796
5,2018-07-14 23:05:00,"Telecom isn't going anywhere anytime soon

Nicholas Rossolillo (Verizon): Over the course of a decade, Americans and their smartphones have become inseparable.",0.8633736968040466,0.02109016291797161,0.11553607881069183,positive,0.8422835469245911
6,2018-07-14 23:05:00,"The country's leading network operator, Verizon, has been an obvious beneficiary of consumers' dependence on their phones.",0.08224084228277206,0.6731157898902893,0.24464330077171326,negative,-0.590874969959259
7,2018-07-14 23:05:00,"Revenue and profit have steadily risen over time from new subscribers, phone and related hardware purchases, and data service plans.",0.9354032278060913,0.014971553348004818,0.04962526261806488,positive,0.9204316735267639
8,2018-07-14 23:05:00,"Though shares have struggled to gain any traction since 2013, the company has increased its dividend every year and currently pays a 4.6% dividend yield.",0.867721676826477,0.02365868166089058,0.10861966758966446,positive,0.8440629839897156
9,2018-07-14 23:05:00,"While Verizon's stock performance has underperformed the overall market's the past few years, it's that dividend that's the compelling reason to own the company.",0.6476975679397583,0.030303845182061195,0.32199856638908386,positive,0.6173937320709229
10,2018-07-14 23:05:00,Detractors would point to a heavy burden of debt to the tune of $119 billion -- a lot of which was added to make acquisitions like Yahoo!,0.056899797171354294,0.5027424693107605,0.4403577446937561,negative,-0.4458426833152771
11,2018-07-14 23:05:00,and AOL -- as a reason to not buy Verizon.,0.056862566620111465,0.11994442343711853,0.8231930732727051,neutral,-0.06308186054229736
12,2018-07-14 23:05:00,"Added to that is disruption from smaller network competitors that have been putting pricing pressure on Verizon, as well as Verizon's own investment into new services such as the next-generation 5G mobile network.",0.02265305072069168,0.9571560025215149,0.020190857350826263,negative,-0.9345029592514038
13,2018-07-14 23:05:00,"There are a few reasons to believe that the stock will be a good income generator for years to come, though.",0.4724973142147064,0.011140549555420876,0.5163620710372925,neutral,0.4613567590713501
14,2018-07-14 23:05:00,"A big boost came at end of last year from corporate tax reform , which management said will increase cash from operations by more than 50% this year.",0.944282591342926,0.017763782292604446,0.03795362263917923,positive,0.9265187978744507
15,2018-07-14 23:05:00,"That helps support the current dividend payout, and a big priority with all those extra funds is to begin reducing debt.",0.8080368041992188,0.014893809333443642,0.17706935107707977,positive,0.7931429743766785
16,2018-07-14 23:05:00,"That, in turn, will also improve the overall picture as interest expense gets reduced.",0.9350330829620361,0.01691855676472187,0.048048343509435654,positive,0.9181145429611206
17,2018-07-14 23:05:00,"Plus, the aforementioned 5G network -- set for initial rollout later this year -- will usher in new lines of business , including putting Verizon in position to compete with internet service providers for residential and business use.",0.924984872341156,0.014232032932341099,0.06078314781188965,positive,0.9107528328895569
18,2018-07-14 23:05:00,"The stock will probably never be a fast-grower, but Verizon's stable but slowly expanding business should provide dividend income for a long time.",0.7822173833847046,0.01329905167222023,0.20448355376720428,positive,0.7689183354377747
19,2018-07-14 23:05:00,"Diabetes drugs could help this drugmaker's dividend keep flowing

Todd Campbell (Eli Lilly & Co.): The number of Americans with diabetes is expected to climb from about 30 million today to nearly 55 million by 2030, according to the Institute for Alternative Futures, and that suggests long-term tailwinds supporting Eli Lilly & Co.'s dividend.",0.9126171469688416,0.04862222447991371,0.0387607105076313,positive,0.8639948964118958
20,2018-07-14 23:05:00,Eli Lilly is one of the planet's biggest diabetes drugmakers.,0.30234023928642273,0.01268570777028799,0.6849740743637085,neutral,0.28965452313423157
21,2018-07-14 23:05:00,"It's been providing insulin to patients since the 1920s, and across its entire diabetes drug lineup, the company generates over 40% of its roughly $22 billion in annual sales from diabetes drugs.",0.08858289569616318,0.005200047045946121,0.9062170386314392,neutral,0.08338284492492676
22,2018-07-14 23:05:00,"Its fastest-growing diabetes drugs are Jardiance, Trulicity, and Basalgar.",0.36081475019454956,0.009253425523638725,0.6299318075180054,neutral,0.3515613377094269
23,2018-07-14 23:05:00,"A once-weekly glucagon-like peptide-1 drug that boosts insulin production, Trulicity saw its sales grow 119% to $2 billion in 2017.",0.9348940253257751,0.015129324048757553,0.04997668415307999,positive,0.9197646975517273
24,2018-07-14 23:05:00,"Jardiance, an SGLT2 inhibitor that increases glucose excretion via urine, saw its sales increase 122% to $448 million last year.",0.9518907070159912,0.017132120206952095,0.030977264046669006,positive,0.9347586035728455
25,2018-07-14 23:05:00,"Basalgar, a biosimilar to Sanofi 's (NYSE: SNY) megablockbuster long-lasting insulin, Lantus, saw its sales skyrocket 402% to $432 million in 2017.",0.8858350515365601,0.04149109870195389,0.07267390191555023,positive,0.8443439602851868
26,2018-07-14 23:05:00,"One risk to future revenue is biosimilar competition to Eli Lilly's top-selling, rapid-acting insulin, Humalog, from Sanofi's recently launched Admelog.",0.1674043834209442,0.6626719236373901,0.16992366313934326,negative,-0.4952675402164459
27,2018-07-14 23:05:00,"Nevertheless, management believes sales can grow 5% per year through 2020.",0.9403221011161804,0.014832119457423687,0.04484573379158974,positive,0.9254899621009827
28,2018-07-14 23:05:00,"Further out, systems that automate insulin delivery or offer greater insight into appropriate insulin doses could add meaningfully to sales.",0.8963544964790344,0.01338102575391531,0.09026449173688889,positive,0.8829734921455383
29,2018-07-14 23:05:00,There's also the potential to reshape treatment for over 1 million people with type 1 diabetes.,0.8002064228057861,0.012116161175072193,0.18767748773097992,positive,0.7880902886390686
30,2018-07-14 23:05:00,One of the company's early-stage research programs is attempting to turn stem cells into insulin-producing beta cells that can be inserted into patients to restore their insulin production.,0.2799495756626129,0.008955429308116436,0.7110949754714966,neutral,0.2709941565990448
31,2018-07-14 23:05:00,"Outside of diabetes, Eli Lilly's also developing cancer, migraine, and rheumatoid arthritis drugs that could increase revenue.",0.9217190146446228,0.01390892919152975,0.06437202543020248,positive,0.9078100919723511
32,2018-07-14 23:05:00,"Overall, Eli Lilly's market-beating 2.6% dividend yield and long-haul tailwinds from targeting an increasingly larger addressable pool of diabetes patients could make holding this stock in long-term income portfolios worthwhile.",0.9340247511863708,0.016043175011873245,0.04993207007646561,positive,0.9179815649986267
33,2018-07-14 23:05:00,"Tim Green(Procter & Gamble): Procter & Gamble, the company behind tried-and-true brands such as Tide, Gillette, Bounty, and Crest, has been around since 1837.",0.08652395755052567,0.011176194064319134,0.9022998809814453,neutral,0.07534776628017426
34,2018-07-14 23:05:00,The company generated $65 billion of sales and more than $13 billion of operating income in fiscal 2017.,0.09227731823921204,0.006194572430104017,0.9015281200408936,neutral,0.08608274906873703
35,2018-07-14 23:05:00,"It has paid a dividend each year since 1890, and it's raised that dividend for 61 consecutive years .",0.45943087339401245,0.011424385011196136,0.5291447639465332,neutral,0.4480064809322357
36,2018-07-14 23:05:00,"Procter & Gamble is having some trouble with revenue growth at the moment, however.",0.022496016696095467,0.9310016632080078,0.04650229588150978,negative,-0.9085056185722351
37,2018-07-14 23:05:00,Its fiscal third quarter featured organic sales growth of just 1% on a year-over-year basis.,0.20979686081409454,0.48448652029037476,0.3057166337966919,negative,-0.2746896743774414
38,2018-07-14 23:05:00,The prospect of a trade war also spells trouble.,0.02965880185365677,0.9376989603042603,0.03264229744672775,negative,-0.9080401659011841
39,2018-07-14 23:05:00,"If things get out of hand, P&G could suffer a decline in sales and profits.",0.01886885240674019,0.9669241905212402,0.014206881634891033,negative,-0.9480553269386292
40,2018-07-14 23:05:00,"On top of that, newer brands like Dollar Shave Club pose a threat to the company's cash-cow businesses.",0.02309383638203144,0.9192789793014526,0.057627204805612564,negative,-0.8961851596832275
41,2018-07-14 23:05:00,But it's hard to bet against P&G and its collection of strong brands in the long run.,0.5484881401062012,0.022734375670552254,0.42877745628356934,positive,0.5257537364959717
42,2018-07-14 23:05:00,"The stock may not outpace the market, given its growth challenges, but that doesn't mean it's not a solid choice for dividend investors.",0.29765936732292175,0.21353256702423096,0.4888080060482025,neutral,0.0841268002986908
43,2018-07-14 23:05:00,"The stock yields about 3.6%, about twice that of the S&P 500.",0.3968062996864319,0.03764890879392624,0.5655447840690613,neutral,0.35915738344192505
44,2018-07-14 23:05:00,"If you want a stock that you can throw into your portfolio and collect dividend payments each and every quarter, Procter & Gamble is for you.",0.027535520493984222,0.005709651857614517,0.9667548537254333,neutral,0.021825868636369705
45,2018-07-14 23:05:00,"10 stocks we like better than Verizon Communications

When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen.",0.1507793366909027,0.023690804839134216,0.8255298137664795,neutral,0.1270885318517685
46,2018-07-14 23:05:00,"After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor , has quadrupled the market.",0.8087436556816101,0.0373060368001461,0.15395022928714752,positive,0.7714376449584961
47,2018-07-14 23:05:00,"*

David and Tom just revealed what they believe are the 10 best stocks for investors to buy right now... and Verizon Communications wasn't one of them!",0.2010251134634018,0.015047824010252953,0.7839270234107971,neutral,0.1859772950410843
48,2018-07-14 23:05:00,That's right -- they think these 10 stocks are even better buys.,0.8146857619285583,0.02307075634598732,0.16224350035190582,positive,0.7916150093078613
49,2018-07-14 23:05:00,Click here to learn about these picks!,0.0694708302617073,0.055800698697566986,0.8747285008430481,neutral,0.01367013156414032
50,2018-07-14 23:05:00,Nicholas Rossolillo owns shares of Verizon Communications.,0.016086306422948837,0.011144391261041164,0.9727693200111389,neutral,0.004941915161907673
51,2018-07-14 23:05:00,Timothy Green has no position in any of the stocks mentioned.,0.010180004872381687,0.0389644093811512,0.9508556127548218,neutral,-0.028784405440092087
52,2018-07-14 23:05:00,Todd Campbell has no position in any of the stocks mentioned.,0.011471163481473923,0.05622142553329468,0.9323073625564575,neutral,-0.044750262051820755
53,2018-07-14 23:05:00,The Motley Fool has no position in any of the stocks mentioned.,0.011856832541525364,0.05262438580393791,0.9355188012123108,neutral,-0.04076755419373512
54,2018-07-14 23:05:00,The Motley Fool has a disclosure policy .,0.016547108069062233,0.01730392687022686,0.9661489725112915,neutral,-0.0007568188011646271
55,2018-07-14 23:05:00,"The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.010204566642642021,0.015637893229722977,0.9741575717926025,neutral,-0.0054333265870809555
